CYP76AD1-beta clade polynucleotides, polypeptides, and uses thereof

Patent metadata

Field	Value
Publication number	US-10767201-B2
Application number	US-201615758372-A
Country	US
Kind code	B2
Filing date	Sep 11, 2016
Priority date	Sep 10, 2015
Publication date	Sep 8, 2020
Grant date	Sep 8, 2020

Abstract

The invention provides recombinant polynucleotides comprising a nucleic acid encoding a CYP76AD6 or related gene and their use for producing L-DOPA from tyrosine and treating dopamine-responsive disorders, such as Parkinson's Disease. The invention also provides recombinant polynucleotides comprising a nucleic acid encoding a CYP76AD1 and/or CYP76AD6, a nucleic acid encoding a DOPA 4.5-dioxygenase (DOD) enzyme, such as Beta vulgaris DODA1, and, in some cases, a nucleic acid encoding betalain related glucosyltransferase, such as M. jalapa gene cyclo-DOPA 5-O-glucosyltransferase (cDOPA5GT), and their use for producing betalains. Finally, the invention provides chimeric polypeptides, expression vectors, cells, compositions, and organisms, including plants, and their uses in various methods of the invention.

First claim

What is claimed is:

1. A recombinant polynucleotide comprising a nucleic acid sequence encoding (i) a cytochrome P450 enzyme CYP76AD6 that converts tyrosine to L-3,4-dihydroxyphenylalanine (L-DOPA), wherein the nucleic acid sequence encoding the CYP76AD6 enzyme is set forth in SEQ ID NO:31, or (ii) a cytochrome P450 enzyme CYP76AD15 that converts tyrosine to L-3,4-dihydroxyphenylalanine (L-DOPA), wherein the nucleic acid sequence encoding the CYP76AD15 enzyme is set forth in SEQ ID NO:35, wherein said nucleic acid encoding the CYP76AD6 enzyme or the CYP76AD15 enzyme is under the control of a promoter, and wherein said promoter is a constitutive promoter, an inducible promoter, a fruit-specific promoter, or a flower-specific promoter.

2. The polynucleotide of claim 1 , wherein the constitutive promoter is a CaMV 35S promoter or a ubiquitin 10 promoter.

3. The polynucleotide of claim 2 , wherein the ubiquitin 10 promoter is a Solanum lycopersicum ubiquitin 10 promoter (SlUb10) or an Arabidopsis ubiquitin-10 promoter.

4. The polynucleotide of claim 1 , wherein the inducible promoter is a galactose-inducible promoter.

5. The polynucleotide of claim 1 , wherein the fruit-specific promoter is E8.

6. The polynucleotide of claim 1 , wherein the flower-specific promoter is Petunia x hybrida chalcone synthase (CHS) promoter.

7. The polynucleotide of claim 1 , wherein said polynucleotide further comprises a nucleic acid encoding a selection marker, wherein said selection marker confers kanamycin resistance and is encoded by the neomycin phosphotransferase II (nptII) gene.

8. A composition comprising the recombinant polynucleotide of claim 1 .

9. An expression vector comprising the recombinant polynucleotide of claim 1 .

10. The expression vector of claim 9 , wherein the vector further comprises a nucleic acid sequence encoding an enzyme that increases tyrosine availability in a cell, wherein said enzyme is an aromatic amino acid hydroxylase (AAH) or a 3-deoxy-D-arabino-heptulosonate 7-phosphate synthase possessing a single point mutation converting leucine at position 175 into glutamine (AroG175), said AroG175 encoded by the nucleic acid sequence set forth in SEQ ID NO: 28, and wherein the cell is a plant cell or a microbial cell.

11. The expression vector of claim 10 , wherein the microbial cell is a yeast, a bacterium, or an alga cell.

12. The expression vector of claim 10 , wherein the nucleic acid sequences encoding the cytochrome P450 enzyme, encoding the AroG175 enzyme, and encoding the AAH enzyme are under the control of a CaMV 35S promoter, or the nucleic acid sequences encoding the cytochrome P450 enzyme, encoding the AroG175 enzyme, and encoding the AAH enzyme are under the control of a SIUb10 promoter.

13. The expression vector of claim 9 , wherein the vector further comprises a nucleic acid sequence encoding a L-3,4-dihydroxyphenylalanine (L-DOPA) 4,5-dioxygenase enzyme.

14. A cell comprising the expression vector of claim 9 , wherein the cell is a plant cell or a microbial cell, and wherein said microbial cell is a yeast, a bacterium, or an alga cell.

Assignees

• Yeda Res & Dev

Inventors

• Aharoni Asaph
• Polturak Guy

Classifications

• A23B2/771

  Organic compounds containing hetero rings · CPC title

• A23B2/762

  Organic compounds containing nitrogen · CPC title

• A23B2/729

  Organic compounds; Microorganisms; Enzymes · CPC title

• G01N33/50

  Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing (measuring or testing processes involving enzymes or microorganisms, compositions or test papers therefor; processes for forming such compositions, condition responsive control in microbiological or enzymological processes C12Q) · CPC title

• C12Y207/01095

  Kanamycin kinase (2.7.1.95), i.e. neomycin-kanamycin phosphotransferase · CPC title